New Jersey A 553: Provides that purchase of insulin is not subject to deductible; requires health insurers to limit copayments and coinsurance for insulin; requires insulin manufacturers to submit report to Commissioner of Banking and Insurance.

Status: Introduced in the Assembly, Referred to Assembly Financial Institutions and Insurance Committee (as of 2022-01-11)

State: New Jersey · Session: 220 · Bill: A 553

Subjects: CONSUMER PRO, DISEASE, HEALTH INSUR, PHARMACEUTIC

Sponsors: Calabrese, Clinton, Karabinchak, Robert J., Quijano, Annette, Benson, Daniel R., DeAngelo, Wayne P., Freiman, Roy, Giblin, Thomas P., Jasey, Mila M., Lampitt, Pamela R., Reynolds-Jackson, Verlina, Stanley, Sterley S., Timberlake, Britnee N.

View New Jersey A 553 on LegisTrack → — full text, sponsors, votes, campaign finance, and cross-state matches.